[{"address1": "2656 State Street", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "619-728-4760", "website": "https://tyra.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SN\u00c5P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Todd  Harris Ph.D.", "age": 45, "title": "Co-Founder, President, CEO, Secretary, Treasurer & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1067050, "exercisedValue": 0, "unexercisedValue": 7050750}, {"maxAge": 1, "name": "Mr. Daniel  Bensen", "age": 49, "title": "Co-Founder & COO", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 737643, "exercisedValue": 0, "unexercisedValue": 4335961}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 627900, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alan  Fuhrman CPA", "age": 67, "title": "Chief Financial Officer", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 763093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert L. Hudkins Ph.D.", "age": 69, "title": "Chief Technology Officer", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronald V. Swanson Ph.D.", "age": 61, "title": "Chief Scientific Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 536188, "exercisedValue": 0, "unexercisedValue": 298928}, {"maxAge": 1, "name": "Mr. Ali D. Fawaz J.D.", "title": "General Counsel", "fiscalYear": 2024, "totalPay": 629230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Honig", "title": "Senior VP of Corporate Development & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Liz  Pagano", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Piyush R. Patel Ph.D.", "age": 59, "title": "Chief Development Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.57, "open": 9.53, "dayLow": 9.1, "dayHigh": 9.83, "regularMarketPreviousClose": 9.57, "regularMarketOpen": 9.53, "regularMarketDayLow": 9.1, "regularMarketDayHigh": 9.83, "payoutRatio": 0.0, "beta": 1.07, "forwardPE": -4.8267326, "volume": 140462, "regularMarketVolume": 140462, "averageVolume": 354393, "averageVolume10days": 393390, "averageDailyVolume10Day": 393390, "bid": 7.05, "ask": 12.26, "bidSize": 1, "askSize": 2, "marketCap": 518485504, "fiftyTwoWeekLow": 6.42, "fiftyTwoWeekHigh": 29.6, "fiftyDayAverage": 9.8426, "twoHundredDayAverage": 14.22, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 196092368, "profitMargins": 0.0, "floatShares": 14033672, "sharesOutstanding": 53178000, "sharesShort": 5260707, "sharesShortPriorMonth": 5101753, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.098900005, "heldPercentInsiders": 0.03688, "heldPercentInstitutions": 1.09086, "shortRatio": 15.44, "shortPercentOfFloat": 0.1451, "impliedSharesOutstanding": 53178000, "bookValue": 6.094, "priceToBook": 1.5999343, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -96436000, "trailingEps": -1.63, "forwardEps": -2.02, "enterpriseToEbitda": -1.733, "52WeekChange": -0.4269461, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 9.75, "targetHighPrice": 33.0, "targetLowPrice": 28.0, "targetMeanPrice": 30.14286, "targetMedianPrice": 30.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 318943008, "totalCashPerShare": 5.998, "ebitda": -113165000, "totalDebt": 6122000, "quickRatio": 22.515, "currentRatio": 22.783, "debtToEquity": 1.892, "returnOnAssets": -0.18996, "returnOnEquity": -0.27035, "freeCashflow": -37792624, "operatingCashflow": -73204000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TYRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.880881, "regularMarketPrice": 9.75, "corporateActions": [], "regularMarketTime": 1751396629, "exchange": "NMS", "messageBoardId": "finmb_650787124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Tyra Biosciences, Inc.", "marketState": "REGULAR", "regularMarketChange": 0.1800003, "regularMarketDayRange": "9.1 - 9.83", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 354393, "fiftyTwoWeekLowChange": 3.33, "fiftyTwoWeekLowChangePercent": 0.5186916, "fiftyTwoWeekRange": "6.42 - 29.6", "fiftyTwoWeekHighChange": -19.85, "fiftyTwoWeekHighChangePercent": -0.6706081, "fiftyTwoWeekChangePercent": -42.69461, "earningsTimestamp": 1746734705, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.63, "epsForward": -2.02, "epsCurrentYear": -2.09939, "priceEpsCurrentYear": -4.644206, "fiftyDayAverageChange": -0.09259987, "fiftyDayAverageChangePercent": -0.00940807, "longName": "Tyra Biosciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "twoHundredDayAverageChange": -4.4700003, "twoHundredDayAverageChangePercent": -0.31434602, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]